stars 1 stars 2 stars 3

Chronic conditions like cancer remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of diseases. Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density at least 10 times higher than that of an MRI. Our solution represents a transformative leap forward not only in the diagnosis and monitoring of various conditions but also in surgical planning. It stands alone as the premier solution offering comprehensive mapping to facilitate personalized treatment. Revealan™ is optimizing ultrasound for better patient outcomes.

EndoCure Ltd. Questions

Hadas Ziso is the Founder, CEO of EndoCure Ltd..

9 people are employed at EndoCure Ltd..

Top EndoCure Ltd. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users